chr4-125317769-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001291303.3(FAT4):​c.1358A>T​(p.Gln453Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.438 in 1,613,882 control chromosomes in the GnomAD database, including 157,747 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q453R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.46 ( 16452 hom., cov: 32)
Exomes 𝑓: 0.44 ( 141295 hom. )

Consequence

FAT4
NM_001291303.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.151

Publications

33 publications found
Variant links:
Genes affected
FAT4 (HGNC:23109): (FAT atypical cadherin 4) The protein encoded by this gene is a member of the protocadherin family. This gene may play a role in regulating planar cell polarity (PCP). Studies in mice suggest that loss of PCP signaling may cause cystic kidney disease, and mutations in this gene have been associated with Van Maldergem Syndrome 2. Alternatively spliced transcript variants have been noted for this gene. [provided by RefSeq, Mar 2014]
FAT4 Gene-Disease associations (from GenCC):
  • Hennekam lymphangiectasia-lymphedema syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • van Maldergem syndrome 2
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • multiple congenital anomalies/dysmorphic syndrome-intellectual disability
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics
  • Hennekam syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • van Maldergem syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.3591885E-5).
BP6
Variant 4-125317769-A-T is Benign according to our data. Variant chr4-125317769-A-T is described in ClinVar as Benign. ClinVar VariationId is 380812.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.56 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FAT4NM_001291303.3 linkc.1358A>T p.Gln453Leu missense_variant Exon 2 of 18 ENST00000394329.9 NP_001278232.1 Q6V0I7A0A6Q8JR05X2G5I7B3KU84

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FAT4ENST00000394329.9 linkc.1358A>T p.Gln453Leu missense_variant Exon 2 of 18 5 NM_001291303.3 ENSP00000377862.4 A0A6Q8JR05
FAT4ENST00000674496.2 linkc.-55+1792A>T intron_variant Intron 1 of 16 ENSP00000501473.2 A0A7P0T1I0

Frequencies

GnomAD3 genomes
AF:
0.459
AC:
69802
AN:
151946
Hom.:
16426
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.566
Gnomad AMI
AF:
0.467
Gnomad AMR
AF:
0.403
Gnomad ASJ
AF:
0.353
Gnomad EAS
AF:
0.254
Gnomad SAS
AF:
0.385
Gnomad FIN
AF:
0.390
Gnomad MID
AF:
0.326
Gnomad NFE
AF:
0.445
Gnomad OTH
AF:
0.439
GnomAD2 exomes
AF:
0.414
AC:
103306
AN:
249260
AF XY:
0.413
show subpopulations
Gnomad AFR exome
AF:
0.573
Gnomad AMR exome
AF:
0.377
Gnomad ASJ exome
AF:
0.365
Gnomad EAS exome
AF:
0.245
Gnomad FIN exome
AF:
0.384
Gnomad NFE exome
AF:
0.444
Gnomad OTH exome
AF:
0.411
GnomAD4 exome
AF:
0.436
AC:
637658
AN:
1461818
Hom.:
141295
Cov.:
71
AF XY:
0.434
AC XY:
315813
AN XY:
727204
show subpopulations
African (AFR)
AF:
0.576
AC:
19287
AN:
33480
American (AMR)
AF:
0.381
AC:
17037
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.364
AC:
9508
AN:
26136
East Asian (EAS)
AF:
0.255
AC:
10110
AN:
39700
South Asian (SAS)
AF:
0.406
AC:
35007
AN:
86254
European-Finnish (FIN)
AF:
0.390
AC:
20788
AN:
53370
Middle Eastern (MID)
AF:
0.354
AC:
2042
AN:
5768
European-Non Finnish (NFE)
AF:
0.448
AC:
498544
AN:
1111994
Other (OTH)
AF:
0.419
AC:
25335
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
24145
48291
72436
96582
120727
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15020
30040
45060
60080
75100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.460
AC:
69882
AN:
152064
Hom.:
16452
Cov.:
32
AF XY:
0.454
AC XY:
33731
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.567
AC:
23519
AN:
41512
American (AMR)
AF:
0.402
AC:
6154
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.353
AC:
1223
AN:
3468
East Asian (EAS)
AF:
0.254
AC:
1306
AN:
5138
South Asian (SAS)
AF:
0.386
AC:
1853
AN:
4806
European-Finnish (FIN)
AF:
0.390
AC:
4131
AN:
10584
Middle Eastern (MID)
AF:
0.340
AC:
100
AN:
294
European-Non Finnish (NFE)
AF:
0.445
AC:
30254
AN:
67950
Other (OTH)
AF:
0.434
AC:
919
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1929
3859
5788
7718
9647
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
626
1252
1878
2504
3130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.400
Hom.:
3650
Bravo
AF:
0.464
TwinsUK
AF:
0.462
AC:
1714
ALSPAC
AF:
0.441
AC:
1699
ESP6500AA
AF:
0.545
AC:
2215
ESP6500EA
AF:
0.427
AC:
3559
ExAC
AF:
0.423
AC:
51126
Asia WGS
AF:
0.343
AC:
1198
AN:
3478
EpiCase
AF:
0.432
EpiControl
AF:
0.427

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 42% of total chromosomes in ExAC -

Jan 11, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 66% of patients studied by a panel of primary immunodeficiencies. Number of patients: 63. Only high quality variants are reported. -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Van Maldergem syndrome 2 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hennekam lymphangiectasia-lymphedema syndrome 2 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
9.6
DANN
Benign
0.82
DEOGEN2
Benign
0.046
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.27
N
LIST_S2
Benign
0.67
T
MetaRNN
Benign
0.000024
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
0.28
N
PhyloP100
0.15
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.31
N
REVEL
Benign
0.018
Sift
Benign
0.33
T
Sift4G
Benign
0.22
T
Polyphen
0.0020
B
Vest4
0.081
MPC
0.15
ClinPred
0.0027
T
GERP RS
-2.6
Varity_R
0.092
gMVP
0.28
Mutation Taster
=87/13
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6847454; hg19: chr4-126238924; COSMIC: COSV67886468; API